A recent study demonstrated that serum ACTN4 levels were dramatically elevated in patients with breast cancer when compared to healthy controls, and serum ACTN4 may be an effective clinical indicator for diagnosing or predicting the clinical outcomes of breast cancer patients [14]. Here, ACTN4 is linked to breast cancer.